Nuveen Asset Management
REGN icon

Nuveen Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$339M Sell
475,630
-211,009
-31% -$150M 0.1% 180
2024
Q3
$722M Buy
686,639
+84,314
+14% +$88.6M 0.2% 93
2024
Q2
$633M Buy
602,325
+63,575
+12% +$66.8M 0.19% 100
2024
Q1
$519M Buy
538,750
+90,281
+20% +$86.9M 0.15% 125
2023
Q4
$394M Buy
448,469
+52,706
+13% +$46.3M 0.13% 144
2023
Q3
$326M Sell
395,763
-56,714
-13% -$46.7M 0.11% 164
2023
Q2
$325M Buy
452,477
+24,581
+6% +$17.7M 0.11% 153
2023
Q1
$352M Buy
427,896
+7,597
+2% +$6.24M 0.13% 149
2022
Q4
$303M Buy
420,299
+36,352
+9% +$26.2M 0.12% 168
2022
Q3
$264M Sell
383,947
-5,807
-1% -$4M 0.11% 180
2022
Q2
$230M Sell
389,754
-2,280
-0.6% -$1.35M 0.09% 212
2022
Q1
$272M Buy
392,034
+8,791
+2% +$6.09M 0.09% 212
2021
Q4
$242M Sell
383,243
-2,830
-0.7% -$1.79M 0.07% 238
2021
Q3
$234M Buy
386,073
+39,278
+11% +$23.8M 0.07% 244
2021
Q2
$194M Sell
346,795
-133,453
-28% -$74.5M 0.06% 305
2021
Q1
$227M Sell
480,248
-353,067
-42% -$167M 0.07% 248
2020
Q4
$403M Sell
833,315
-792,931
-49% -$383M 0.14% 141
2020
Q3
$910M Sell
1,626,246
-80,543
-5% -$45.1M 0.35% 59
2020
Q2
$1.06B Buy
1,706,789
+492,173
+41% +$307M 0.43% 45
2020
Q1
$593M Buy
1,214,616
+428,361
+54% +$209M 0.29% 76
2019
Q4
$295M Buy
786,255
+539,224
+218% +$202M 0.11% 177
2019
Q3
$68.5M Sell
247,031
-105,784
-30% -$29.3M 0.03% 519
2019
Q2
$110M Buy
352,815
+308,740
+700% +$96.6M 0.04% 396
2019
Q1
$18.1M Buy
44,075
+22,244
+102% +$9.13M 0.1% 319
2018
Q4
$8.15M Buy
21,831
+40
+0.2% +$14.9K 0.05% 422
2018
Q3
$8.8M Buy
21,791
+2,197
+11% +$888K 0.05% 455
2018
Q2
$6.76M Sell
19,594
-167
-0.8% -$57.6K 0.04% 450
2018
Q1
$6.81M Sell
19,761
-21,650
-52% -$7.46M 0.04% 438
2017
Q4
$15.6M Sell
41,411
-2,825
-6% -$1.06M 0.1% 304
2017
Q3
$19.8M Buy
44,236
+22,128
+100% +$9.89M 0.13% 247
2017
Q2
$10.9M Sell
22,108
-2,168
-9% -$1.06M 0.07% 390
2017
Q1
$9.41M Buy
24,276
+4,389
+22% +$1.7M 0.06% 431
2016
Q4
$7.3M Sell
19,887
-327
-2% -$120K 0.04% 538
2016
Q3
$8.13M Buy
20,214
+89
+0.4% +$35.8K 0.05% 437
2016
Q2
$7.03M Sell
20,125
-386
-2% -$135K 0.04% 436
2016
Q1
$7.39K Sell
20,511
-10,166
-33% -$3.66K 0.04% 398
2015
Q4
$16.7K Buy
30,677
+170
+0.6% +$92 0.09% 245
2015
Q3
$14.2K Buy
30,507
+19
+0.1% +$9 0.08% 276
2015
Q2
$15.6K Sell
30,488
-3,882
-11% -$1.98K 0.08% 291
2015
Q1
$15.5M Buy
34,370
+5,109
+17% +$2.31M 0.09% 309
2014
Q4
$12M Sell
29,261
-6,334
-18% -$2.6M 0.07% 347
2014
Q3
$12.8M Sell
35,595
-1,465
-4% -$528K 0.08% 324
2014
Q2
$10.5M Sell
37,060
-13,032
-26% -$3.68M 0.06% 354
2014
Q1
$15M Sell
50,092
-18,140
-27% -$5.45M 0.09% 279
2013
Q4
$18.8M Sell
68,232
-6,707
-9% -$1.85M 0.12% 241
2013
Q3
$23.4M Sell
74,939
-20,003
-21% -$6.26M 0.15% 187
2013
Q2
$21.4M Buy
+94,942
New +$21.4M 0.14% 196